Analysis

Bayh-Dole Could Be A Drug Pricing Fix, If The Feds Want It

Law360 (March 23, 2018, 6:26 PM EDT) -- As the debate over rising drug prices continues to rage, one advocacy organization is pushing the federal government to take advantage of a tool already in its belt: the Bayh-Dole Act, which allows the feds to take ownership of patents it helped fund or force companies to provide licenses for those patents.

While experts seem skeptical that the government is going to start taking patents for itself, as Knowledge Ecology International is urging, they say Bayh-Dole may just be the leverage needed to get drug companies to adjust prices on their own. However, experts cautioned against hope for rapid change, as...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!